TY - JOUR AU - Manjelievskaia, J. AU - Erck, D. AU - Piracha, S. AU - Schrager, L. PY - 2016 DA - 2016// TI - Drug-resistant TB: deadly, costly and in need of a vaccine JO - Trans R Soc Trop Med Hyg VL - 110 UR - https://doi.org/10.1093/trstmh/trw006 DO - 10.1093/trstmh/trw006 ID - Manjelievskaia2016 ER - TY - BOOK PY - 2016 DA - 2016// TI - Global tuberculosis report 2016 PB - World Health Organization CY - Geneva ID - ref2 ER - TY - JOUR AU - Kendall, E. A. AU - Fojo, A. T. AU - Dowdy, D. W. PY - 2016 DA - 2016// TI - Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis JO - Lancet Respir Med VL - 5 UR - https://doi.org/10.1016/S2213-2600(16)30423-4 DO - 10.1016/S2213-2600(16)30423-4 ID - Kendall2016 ER - TY - JOUR AU - Ramappa, V. AU - Aithal, G. P. PY - 2013 DA - 2013// TI - Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management JO - J Clin Exp Hepatol. VL - 3 UR - https://doi.org/10.1016/j.jceh.2012.12.001 DO - 10.1016/j.jceh.2012.12.001 ID - Ramappa2013 ER - TY - JOUR AU - Beebe, A. AU - Seaworth, B. AU - Patil, N. PY - 2015 DA - 2015// TI - Rifampicin-induced nephrotoxicity in a tuberculosis patient JO - J Clin Tuberc Other Mycobact Dis VL - 1 UR - https://doi.org/10.1016/j.jctube.2015.09.001 DO - 10.1016/j.jctube.2015.09.001 ID - Beebe2015 ER - TY - BOOK AU - Berkrot, B. PY - 2011 DA - 2011// TI - Success rates for experimental drugs falls: study PB - Thomson Reuters CY - Toronto ID - Berkrot2011 ER - TY - JOUR AU - Payne, D. J. AU - Gwynn, M. N. AU - Holmes, D. J. AU - Pompliano, D. L. PY - 2007 DA - 2007// TI - Drugs for bad bugs: confronting the challenges of antibacterial discovery JO - Nat Rev Drug Discov. VL - 6 UR - https://doi.org/10.1038/nrd2201 DO - 10.1038/nrd2201 ID - Payne2007 ER - TY - BOOK AU - Thomson, R. PY - 2012 DA - 2012// TI - knowledge-based drug repositioningto drive R&D productivity PB - Thompson Reuters CY - Toronto ID - Thomson2012 ER - TY - BOOK AU - Kerber, R. PY - 2003 DA - 2003// TI - Old drugs, new life PB - The Boston Globe CY - Boston ID - Kerber2003 ER - TY - STD TI - Konemann S, Dorr M, Felix SB (2017) Cardiac immunomodulation. In: Nusinovitch U (ed) The heart in rheumatic, autoimmune and inflammatory diseases. pp 681–714 ID - ref10 ER - TY - JOUR AU - Palomino, J. C. AU - Martin, A. PY - 2013 DA - 2013// TI - Is repositioning of drugs a viable alternative in the treatment of tuberculosis? JO - J Antimicrob Chemother VL - 68 UR - https://doi.org/10.1093/jac/dks405 DO - 10.1093/jac/dks405 ID - Palomino2013 ER - TY - JOUR AU - Zumla, A. AU - Nahid, P. AU - Cole, S. T. PY - 2013 DA - 2013// TI - Advances in the development of new tuberculosis drugs and treatment regimens JO - Nat Rev Drug Discov VL - 12 UR - https://doi.org/10.1038/nrd4001 DO - 10.1038/nrd4001 ID - Zumla2013 ER - TY - JOUR AU - Carroll, M. W. AU - Jeon, D. AU - Mountz, J. M. AU - Lee, J. D. AU - Jeong, Y. J. AU - Zia, N. PY - 2013 DA - 2013// TI - Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis JO - Antimicrob Agents Chemother VL - 57 UR - https://doi.org/10.1128/AAC.00753-13 DO - 10.1128/AAC.00753-13 ID - Carroll2013 ER - TY - JOUR AU - Ramón-García, S. AU - González del Río, R. AU - Villarejo, A. S. AU - Sweet, G. D. AU - Cunningham, F. AU - Barros, D. PY - 2016 DA - 2016// JO - Repurposing clinically approved cephalosporins for tuberculosis therapy. VL - 6 ID - Ramón-García2016 ER - TY - JOUR AU - Leegwater-Kim, J. AU - Waters, C. PY - 2007 DA - 2007// TI - Role of tolcapone in the treatment of Parkinson’s disease JO - Expert Rev Neurother VL - 7 UR - https://doi.org/10.1586/14737175.7.12.1649 DO - 10.1586/14737175.7.12.1649 ID - Leegwater-Kim2007 ER - TY - JOUR AU - Maitra, A. AU - Bates, S. AU - Shaik, M. AU - Evangelopoulos, D. AU - Abubakar, I. AU - McHugh, T. D. PY - 2016 DA - 2016// TI - Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs JO - Br Med Bull VL - 118 UR - https://doi.org/10.1093/bmb/ldw019 DO - 10.1093/bmb/ldw019 ID - Maitra2016 ER - TY - JOUR AU - Lechartier, B. AU - Rybniker, J. AU - Zumla, A. AU - Cole, S. T. PY - 2014 DA - 2014// TI - Tuberculosis drug discovery in the post-post-genomic era JO - EMBO Mol Med VL - 6 ID - Lechartier2014 ER - TY - JOUR AU - Brindha, S. AU - Sundaramurthi, J. C. AU - Velmurugan, D. AU - Vincent, S. AU - Gnanadoss, J. J. PY - 2016 DA - 2016// TI - Docking-based virtual screening of known drugs against murE of Mycobacterium tuberculosis towards repurposing for TB JO - Bioinformation VL - 12 UR - https://doi.org/10.6026/97320630012368 DO - 10.6026/97320630012368 ID - Brindha2016 ER - TY - JOUR AU - Brindha, S. AU - Vincent, S. AU - Velmurugan, D. AU - Ananthakrishnan, D. AU - Sundaramurthi, J. C. AU - Gnanadoss, J. J. PY - 2017 DA - 2017// TI - Bioinformatics approach to prioritize known drugs towards repurposing for tuberculosis JO - Med Hypotheses VL - 103 UR - https://doi.org/10.1016/j.mehy.2017.04.005 DO - 10.1016/j.mehy.2017.04.005 ID - Brindha2017 ER - TY - JOUR AU - Kinnings, S. L. AU - Xie, L. AU - Fung, K. H. AU - Jackson, R. M. AU - Xie, L. AU - Bourne, P. E. PY - 2010 DA - 2010// TI - The Mycobacterium tuberculosis drugome and its polypharmacological implications JO - PLoS Comput Biol VL - 6 UR - https://doi.org/10.1371/journal.pcbi.1000976 DO - 10.1371/journal.pcbi.1000976 ID - Kinnings2010 ER - TY - JOUR AU - Ramakrishnan, G. AU - Chandra, N. R. AU - Srinivasan, N. PY - 2015 DA - 2015// TI - Recognizing drug targets using evolutionary information: implications for repurposing FDA-approved drugs against Mycobacterium tuberculosis H37Rv JO - Mol BioSyst VL - 11 UR - https://doi.org/10.1039/C5MB00476D DO - 10.1039/C5MB00476D ID - Ramakrishnan2015 ER - TY - JOUR AU - Yamanishi, Y. AU - Kotera, M. AU - Kanehisa, M. AU - Goto, S. PY - 2010 DA - 2010// TI - Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework JO - Bioinformatics VL - 26 UR - https://doi.org/10.1093/bioinformatics/btq176 DO - 10.1093/bioinformatics/btq176 ID - Yamanishi2010 ER - TY - JOUR AU - Seal, A. AU - Ahn, Y. Y. AU - Wild, D. J. PY - 2015 DA - 2015// TI - Optimizing drug-target interaction prediction based on random walk on heterogeneous networks JO - J Cheminform VL - 7 UR - https://doi.org/10.1186/s13321-015-0089-z DO - 10.1186/s13321-015-0089-z ID - Seal2015 ER - TY - JOUR AU - Isik, Z. AU - Baldow, C. AU - Cannistraci, C. V. AU - Schroeder, M. PY - 2015 DA - 2015// TI - Drug target prioritization by perturbed gene expression and network information JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep17417 DO - 10.1038/srep17417 ID - Isik2015 ER - TY - JOUR AU - Cheng, F. AU - Liu, C. AU - Jiang, J. AU - Lu, W. AU - Li, W. AU - Liu, G. PY - 2012 DA - 2012// TI - Prediction of drug-target interactions and drug repositioning via network-based inference JO - PLoS Comput Biol VL - 8 UR - https://doi.org/10.1371/journal.pcbi.1002503 DO - 10.1371/journal.pcbi.1002503 ID - Cheng2012 ER - TY - JOUR AU - Zhou, T. AU - Ren, J. AU - Medo, M. AU - Zhang, Y. C. PY - 2007 DA - 2007// TI - Bipartite network projection and personal recommendation JO - Phys Rev E: Stat, Nonlin, Soft Matter Phys VL - 76 UR - https://doi.org/10.1103/PhysRevE.76.046115 DO - 10.1103/PhysRevE.76.046115 ID - Zhou2007 ER - TY - JOUR AU - Guo, Z. R. PY - 2011 DA - 2011// TI - Drug promiscuity JO - Yao Xue Xue Bao VL - 46 ID - Guo2011 ER - TY - JOUR AU - Law, V. AU - Knox, C. AU - Djoumbou, Y. AU - Jewison, T. AU - Guo, A. C. AU - Liu, Y. PY - 2014 DA - 2014// TI - DrugBank 4.0: shedding new light on drug metabolism JO - Nucleic Acids Res VL - 42 UR - https://doi.org/10.1093/nar/gkt1068 DO - 10.1093/nar/gkt1068 ID - Law2014 ER - TY - JOUR AU - Knox, C. AU - Law, V. AU - Jewison, T. AU - Liu, P. AU - Ly, S. AU - Frolkis, A. PY - 2011 DA - 2011// TI - DrugBank 3.0: a comprehensive resource for ‘omics’ research on drugs JO - Nucleic Acids Res VL - 39 UR - https://doi.org/10.1093/nar/gkq1126 DO - 10.1093/nar/gkq1126 ID - Knox2011 ER - TY - JOUR AU - Wishart, D. S. AU - Knox, C. AU - Guo, A. C. AU - Cheng, D. AU - Shrivastava, S. AU - Tzur, D. PY - 2008 DA - 2008// TI - DrugBank: a knowledgebase for drugs, drug actions and drug targets JO - Nucleic Acids Res VL - 36 UR - https://doi.org/10.1093/nar/gkm958 DO - 10.1093/nar/gkm958 ID - Wishart2008 ER - TY - JOUR AU - Wishart, D. S. AU - Knox, C. AU - Guo, A. C. AU - Shrivastava, S. AU - Hassanali, M. AU - Stothard, P. PY - 2006 DA - 2006// TI - DrugBank: a comprehensive resource for in silico drug discovery and exploration JO - Nucleic Acids Res VL - 34 UR - https://doi.org/10.1093/nar/gkj067 DO - 10.1093/nar/gkj067 ID - Wishart2006 ER - TY - JOUR AU - Huntley, R. P. AU - Sawford, T. AU - Mutowo-Meullenet, P. AU - Shypitsyna, A. AU - Bonilla, C. AU - Martin, M. J. PY - 2015 DA - 2015// TI - The GOA database: gene ontology annotation updates for 2015 JO - Nucleic Acids Res VL - 43 UR - https://doi.org/10.1093/nar/gku1113 DO - 10.1093/nar/gku1113 ID - Huntley2015 ER - TY - JOUR AU - Binns, D. AU - Dimmer, E. AU - Huntley, R. AU - Barrell, D. AU - O’Donovan, C. AU - Apweiler, R. PY - 2009 DA - 2009// TI - QuickGO: a web-based tool for gene ontology searching JO - Bioinformatics VL - 25 UR - https://doi.org/10.1093/bioinformatics/btp536 DO - 10.1093/bioinformatics/btp536 ID - Binns2009 ER - TY - JOUR AU - Chan, S. AU - Segelke, B. AU - Lekin, T. AU - Krupka, H. AU - Cho, U. S. AU - Kim, M. Y. PY - 2004 DA - 2004// TI - Crystal structure of the Mycobacterium tuberculosis dUTPase: insights into the catalytic mechanism JO - J Mol Biol VL - 341 UR - https://doi.org/10.1016/j.jmb.2004.06.028 DO - 10.1016/j.jmb.2004.06.028 ID - Chan2004 ER - TY - JOUR AU - Carroll, P. AU - Faray-Kele, M. C. AU - Parish, T. PY - 2011 DA - 2011// TI - Identifying vulnerable pathways in Mycobacterium tuberculosis by using a knockdown approach JO - Appl Environ Microbiol VL - 77 UR - https://doi.org/10.1128/AEM.02880-10 DO - 10.1128/AEM.02880-10 ID - Carroll2011 ER - TY - JOUR AU - Bermingham, A. AU - Derrick, J. P. PY - 2002 DA - 2002// TI - The folic acid biosynthesis pathway in bacteria: evaluation of potential for antibacterial drug discovery JO - BioEssays VL - 24 UR - https://doi.org/10.1002/bies.10114 DO - 10.1002/bies.10114 ID - Bermingham2002 ER - TY - JOUR AU - Baca, A. M. AU - Sirawaraporn, R. AU - Turley, S. AU - Sirawaraporn, W. AU - Hol, W. G. PY - 2000 DA - 2000// TI - Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action JO - J Mol Biol VL - 302 UR - https://doi.org/10.1006/jmbi.2000.4094 DO - 10.1006/jmbi.2000.4094 ID - Baca2000 ER - TY - JOUR AU - Liu, T. AU - Wang, B. AU - Guo, J. AU - Zhou, Y. AU - Julius, M. AU - Njire, M. PY - 2015 DA - 2015// TI - Role of folP1 and folP2 genes in the action of sulfamethoxazole and trimethoprim against mycobacteria JO - J Microbiol Biotechnol VL - 25 UR - https://doi.org/10.4014/jmb.1503.03053 DO - 10.4014/jmb.1503.03053 ID - Liu2015 ER - TY - JOUR AU - Skold, O. PY - 2000 DA - 2000// TI - Sulfonamide resistance: mechanisms and trends JO - Drug Resist Updat VL - 3 UR - https://doi.org/10.1054/drup.2000.0146 DO - 10.1054/drup.2000.0146 ID - Skold2000 ER - TY - JOUR AU - Hammoudeh, D. I. AU - Zhao, Y. AU - White, S. W. AU - Lee, R. E. PY - 2013 DA - 2013// TI - Replacing sulfa drugs with novel DHPS inhibitors JO - Future Med Chem VL - 5 UR - https://doi.org/10.4155/fmc.13.97 DO - 10.4155/fmc.13.97 ID - Hammoudeh2013 ER - TY - JOUR AU - Hevener, K. E. AU - Yun, M. K. AU - Qi, J. AU - Kerr, I. D. AU - Babaoglu, K. AU - Hurdle, J. G. PY - 2010 DA - 2010// TI - Structural studies of pterin-based inhibitors of dihydropteroate synthase JO - J Med Chem VL - 53 UR - https://doi.org/10.1021/jm900861d DO - 10.1021/jm900861d ID - Hevener2010 ER - TY - JOUR AU - Zhao, Y. AU - Hammoudeh, D. AU - Yun, M. K. AU - Qi, J. AU - White, S. W. AU - Lee, R. E. PY - 2012 DA - 2012// TI - Structure-based design of novel pyrimido[4,5-c]pyridazine derivatives as dihydropteroate synthase inhibitors with increased affinity JO - ChemMedChem VL - 7 UR - https://doi.org/10.1002/cmdc.201200049 DO - 10.1002/cmdc.201200049 ID - Zhao2012 ER - TY - JOUR AU - Villela, A. D. AU - Sanchez-Quitian, Z. A. AU - Ducati, R. G. AU - Santos, D. S. AU - Basso, L. A. PY - 2011 DA - 2011// TI - Pyrimidine salvage pathway in Mycobacterium tuberculosis JO - Curr Med Chem VL - 18 UR - https://doi.org/10.2174/092986711795029555 DO - 10.2174/092986711795029555 ID - Villela2011 ER - TY - JOUR AU - Vanheusden, V. AU - Rompaey, P. AU - Munier-Lehmann, H. AU - Pochet, S. AU - Herdewijn, P. AU - Calenbergh, S. PY - 2003 DA - 2003// TI - Thymidine and thymidine-5′-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase JO - Bioorg Med Chem Lett VL - 13 UR - https://doi.org/10.1016/S0960-894X(03)00643-7 DO - 10.1016/S0960-894X(03)00643-7 ID - Vanheusden2003 ER - TY - JOUR AU - Sassetti, C. M. AU - Boyd, D. H. AU - Rubin, E. J. PY - 2003 DA - 2003// TI - Genes required for mycobacterial growth defined by high density mutagenesis JO - Mol Microbiol VL - 48 UR - https://doi.org/10.1046/j.1365-2958.2003.03425.x DO - 10.1046/j.1365-2958.2003.03425.x ID - Sassetti2003 ER - TY - JOUR AU - Vertessy, B. G. AU - Toth, J. PY - 2009 DA - 2009// TI - Keeping uracil out of DNA: physiological role, structure and catalytic mechanism of dUTPases JO - Acc Chem Res VL - 42 UR - https://doi.org/10.1021/ar800114w DO - 10.1021/ar800114w ID - Vertessy2009 ER - TY - JOUR AU - El-Hajj, H. H. AU - Zhang, H. AU - Weiss, B. PY - 1988 DA - 1988// TI - Lethality of a dut (deoxyuridine triphosphatase) mutation in Escherichia coli JO - J Bacteriol. VL - 170 UR - https://doi.org/10.1128/jb.170.3.1069-1075.1988 DO - 10.1128/jb.170.3.1069-1075.1988 ID - El-Hajj1988 ER - TY - JOUR AU - Gadsden, M. H. AU - McIntosh, E. M. AU - Game, J. C. AU - Wilson, P. J. AU - Haynes, R. H. PY - 1993 DA - 1993// TI - dUTP pyrophosphatase is an essential enzyme in Saccharomyces cerevisiae JO - EMBO J VL - 12 UR - https://doi.org/10.1002/j.1460-2075.1993.tb06127.x DO - 10.1002/j.1460-2075.1993.tb06127.x ID - Gadsden1993 ER - TY - JOUR AU - Kaur, P. AU - Agarwal, S. AU - Datta, S. PY - 2009 DA - 2009// TI - Delineating bacteriostatic and bactericidal targets in mycobacteria using IPTG inducible antisense expression JO - PLoS ONE VL - 4 UR - https://doi.org/10.1371/journal.pone.0005923 DO - 10.1371/journal.pone.0005923 ID - Kaur2009 ER - TY - JOUR AU - Ramachandran, V. AU - Singh, R. AU - Yang, X. AU - Tunduguru, R. AU - Mohapatra, S. AU - Khandelwal, S. PY - 2013 DA - 2013// TI - Genetic and chemical knockdown: a complementary strategy for evaluating an anti-infective target JO - Adv Appl Bioinform Chem VL - 6 ID - Ramachandran2013 ER - TY - JOUR AU - Black, P. A. AU - Warren, R. M. AU - Louw, G. E. AU - Helden, P. D. AU - Victor, T. C. AU - Kana, B. D. PY - 2014 DA - 2014// TI - Energy metabolism and drug efflux in Mycobacterium tuberculosis JO - Antimicrob Agents Chemother VL - 58 UR - https://doi.org/10.1128/AAC.02293-13 DO - 10.1128/AAC.02293-13 ID - Black2014 ER - TY - JOUR AU - Dhiman, R. K. AU - Mahapatra, S. AU - Slayden, R. A. AU - Boyne, M. E. AU - Lenaerts, A. AU - Hinshaw, J. C. PY - 2009 DA - 2009// TI - Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non-replicating persistence JO - Mol Microbiol VL - 72 UR - https://doi.org/10.1111/j.1365-2958.2009.06625.x DO - 10.1111/j.1365-2958.2009.06625.x ID - Dhiman2009 ER - TY - JOUR AU - Braback, M. AU - Riesbeck, K. AU - Forsgren, A. PY - 2002 DA - 2002// TI - Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones JO - Antimicrob Agents Chemother VL - 46 UR - https://doi.org/10.1128/AAC.46.4.1114-1116.2002 DO - 10.1128/AAC.46.4.1114-1116.2002 ID - Braback2002 ER - TY - JOUR AU - Eliopoulos, G. M. AU - Wennersten, C. B. PY - 2002 DA - 2002// TI - Antimicrobial activity of quinupristin-dalfopristin combined with other antibiotics against vancomycin-resistant enterococci JO - Antimicrob Agents Chemother VL - 46 UR - https://doi.org/10.1128/AAC.46.5.1319-1324.2002 DO - 10.1128/AAC.46.5.1319-1324.2002 ID - Eliopoulos2002 ER - TY - JOUR AU - Evans, J. C. AU - Trujillo, C. AU - Wang, Z. AU - Eoh, H. AU - Ehrt, S. AU - Schnappinger, D. PY - 2016 DA - 2016// TI - Validation of CoaBC as a bactericidal target in the coenzyme a pathway of Mycobacterium tuberculosis JO - ACS Infect Dis. VL - 2 UR - https://doi.org/10.1021/acsinfecdis.6b00150 DO - 10.1021/acsinfecdis.6b00150 ID - Evans2016 ER - TY - JOUR AU - Manjunatha, U. H. AU - Rao, S. P. S. AU - Kondreddi, R. R. AU - Noble, C. G. AU - Camacho, L. R. AU - Tan, B. H. PY - 2015 DA - 2015// TI - Direct inhibitors of InhA are active against Mycobacterium tuberculosis JO - Sci Transl Med. VL - 7 UR - https://doi.org/10.1126/scitranslmed.3010597 DO - 10.1126/scitranslmed.3010597 ID - Manjunatha2015 ER - TY - JOUR AU - Alland, C. AU - Moreews, F. AU - Boens, D. AU - Carpentier, M. AU - Chiusa, S. AU - Lonquety, M. PY - 2005 DA - 2005// TI - RPBS: a web resource for structural bioinformatics JO - Nucleic Acids Res. VL - 33 UR - https://doi.org/10.1093/nar/gki477 DO - 10.1093/nar/gki477 ID - Alland2005 ER - TY - JOUR AU - Shannon, P. AU - Markiel, A. AU - Ozier, O. AU - Baliga, N. S. AU - Wang, J. T. AU - Ramage, D. PY - 2003 DA - 2003// TI - Cytoscape: a software environment for integrated models of biomolecular interaction networks JO - Genome Res VL - 13 UR - https://doi.org/10.1101/gr.1239303 DO - 10.1101/gr.1239303 ID - Shannon2003 ER -